Monthly Research Review: Journal of Diabetes Investigation (Vol. 16, Issue 3, 2025)
This issue presents a diverse collection of groundbreaking studies aimed at refining clinical strategies, introducing digital solutions, and mapping long-term risks for individuals across the glycemic spectrum. Key themes explore non-invasive digital therapeutic platforms to improve glucose levels, intensive combination regimens designed to achieve type 2 diabetes remission, and the distinct postpartum risks of early-onset gestational diabetes.
Additionally, researchers delve into critical risk factors such as blood pressure anomalies in diabetic neuropathy, sex hormone levels and long-term mortality, insulin requirements during severe acute illness, and the definitive risks of smoking on kidney health. Together, these studies bridge basic research and real-world clinical care to support better outcomes for patients and families.
This article was created with the assistance of AI. Although the content is based on original research articles and other academic sources, errors may be present. Please verify the information using the original articles and consult qualified healthcare professionals for medical advice.
Relationship between the progression of diabetic polyneuropathy and impaired circadian blood pressure variability
Research Objective: To investigate how the worsening of diabetic nerve damage (polyneuropathy) affects the natural 24-hour variation in blood pressure.
Methods: Researchers monitored 154 patients hospitalized for high blood sugar using a 24-hour blood pressure monitor. They evaluated nerve function (nerve conduction studies), heart variability (Holter ECG), kidney health, and graded the nerve damage severity using standardized classification scales.
Main Findings: Normally, blood pressure drops at night. In patients with advanced nerve damage, this nighttime drop was diminished. Instead, many exhibited a "riser" pattern, where blood pressure remains high or increases during the night. Nerve damage severity and urinary albumin excretion (kidney function marker) were both independently linked to this high-risk "riser" pattern.
Clinical Significance: Impaired 24-hour blood pressure rhythms are a major risk factor for heart disease. Worsening nerve damage is closely linked to this impairment, highlighting the connection between nerve pathways and cardiovascular health.
Key Point for Patients: Worsening diabetic nerve damage can disrupt how your body regulates blood pressure at night. Work with your doctor to screen for both nerve health and nighttime blood pressure fluctuations to protect your heart.
Association between endogenous estradiol, testosterone, and long-term mortality in adults with prediabetes and diabetes: Evidence from NHANES database
Research Objective: To evaluate whether levels of natural sex hormones (testosterone and estradiol) are related to long-term all-cause and cardiovascular death in people with prediabetes and diabetes.
Methods: A database study analyzing 3,665 participants aged 50–79. Serum hormone levels were examined alongside follow-up death records up to late 2019.
Main Findings: In men with prediabetes, higher levels of testosterone and estradiol were associated with lower all-cause and cardiovascular mortality risks. In women with diabetes, higher estradiol levels or higher testosterone-to-estradiol (T/E) ratios were tied to lower all-cause mortality risk.
Clinical Significance: Naturally occurring sex hormones may have protective qualities in individuals with altered blood sugar metabolism, with distinct protective pathways seen between men and women.
Key Point for Patients: Balance in natural hormone levels appears to correlate with better long-term survival in people with prediabetes and diabetes. Speak to your provider about how hormones and metabolic health influence each other.
Gestational diabetes in early pregnancy is associated with postpartum glucose intolerance: A perspective from the diabetes and pregnancy outcome for mother and baby study in Japan
Research Objective: To compare pregnancy outcomes and long-term postpartum blood sugar tolerance between women diagnosed with early gestational diabetes (before 20 weeks) versus late gestational diabetes (at or after 24 weeks).
Methods: Analyzed data from 1,275 mother-infant pairs, with 924 women completing postpartum blood sugar testing.
Main Findings: Overall pregnancy outcomes were largely similar between the two groups. However, overweight/obese women with early GDM had a 2.5-fold higher rate of preterm birth. Most notably, women diagnosed with early GDM had a 1.5 times higher risk of postpartum glucose intolerance (difficulty managing blood sugar after giving birth) compared to those diagnosed late in pregnancy.
Clinical Significance: Early-onset gestational diabetes serves as a strong warning sign for ongoing blood sugar problems after delivery, identifying patients who need long-term metabolic follow-ups.
Key Point for Patients: If you are diagnosed with gestational diabetes early in pregnancy (before 20 weeks), it is highly recommended to continue regular blood sugar screenings even after your baby is born.
An interventional study of digital therapy on blood glucose and weight management in Chinese patients with type 2 diabetes
Research Objective: To determine whether a 3-month smartphone app-based digital therapy intervention could improve blood sugar and weight in patients with type 2 diabetes.
Methods: A real-world intervention tracking 3,902 adults with type 2 diabetes. Participants recorded their weight and glucose levels at least weekly and attended online weekly diabetes education programs.
Main Findings: Over 3 months, participants saw a significant drop in fasting blood glucose, post-meal glucose, and body weight. Those who were highly motivated and logged data consistently (at least once every 7 days) achieved significantly greater weight loss (average of 3.01 kg lost) compared to less active users (0.36 kg lost).
Clinical Significance: Mobile app-based health tracking combined with ongoing education is a viable, effective, and scalable option to help patients control blood sugar and manage body weight.
Key Point for Patients: Using a smartphone application to record your blood sugar and weight regularly can help keep you motivated and lead to better weight loss and overall diabetes management.
miR-130a-3p enhances autophagy through the YY1/PI3K/AKT/mTOR signaling pathway to regulate macrophage polarization and alleviate diabetic retinopathy
Research Objective: To discover how a tiny regulatory molecule, miR-130a-3p, works at the cellular level to slow down the progression of diabetic retinopathy (eye disease).
Methods: A laboratory-based molecular study utilizing mice with diabetes alongside human immune cell cultures exposed to high-glucose conditions.
Main Findings: High glucose environments reduce the protective molecule miR-130a-3p. By artificially increasing its expression, researchers successfully reduced inflammation, promoted "autophagy" (the cellular process of cleaning up damaged parts), and prevented immune cells (macrophages) from turning into highly inflammatory types, reducing retinal damage in mice.
Clinical Significance: This discovery uncovers a key biological pathway (YY1/PI3K/Akt/mTOR) that could be targeted to develop new cellular therapies or medications to prevent blindness caused by diabetes.
Key Point for Patients: Scientists are discovering new molecular pathways that protect the eyes from high blood sugar. These laboratory findings lay the groundwork for potential future eye treatments.
Maximum insulin dose in patients admitted to the intensive care units with severe COVID-19 in the "Cross ICU Searchable Information System" study: A multicenter retrospective cohort study
Research Objective: To find the average maximum daily insulin dose required by patients with severe COVID-19 in intensive care, and identify what factors predict higher insulin needs.
Methods: A retrospective study evaluating clinical data of 788 Japanese ICU patients who were placed on ventilators or ECMO (heart-lung machines).
Main Findings: The average peak insulin requirement was quite high, about 46.0 Units per day, and this peak typically occurred about a week into their ICU stay. Patients who were male, had a higher BMI, had higher pre-existing HbA1c, or had kidney failure required significantly higher insulin doses.
Clinical Significance: Severe infections like COVID-19 cause massive body stress and insulin resistance. Recognizing which patients will need high doses of insulin can help ICU doctors anticipate and control blood sugar better.
Key Point for Patients: Critical illnesses drastically increase blood sugar and insulin needs. High-quality diabetes care in the ICU is essential to help the body fight off severe infections.
Diabetes remission in newly diagnosed type 2 diabetes mellitus through short-term continuous subcutaneous insulin infusion intensive therapy combined with low-carbohydrate diet treatment
Research Objective: To evaluate if a combination of early intensive insulin pump therapy and a low-carbohydrate diet (LCD) can safely achieve diabetes remission in people newly diagnosed with type 2 diabetes.
Methods: Patients were randomized into two groups: conventional lifestyle guidelines + insulin pump, or intensive low-carb guidelines + insulin pump. Continuous glucose monitoring was used to track success.
Main Findings: The intensive (low-carb diet) group spent more "time in range" (optimal blood sugar hours) and achieved significantly higher diabetes remission rates. They also saw greater improvements in HbA1c, insulin sensitivity, weight loss, visceral fat reduction, and cholesterol metrics, without an increase in low blood sugar (hypoglycemia) events.
Clinical Significance: Combining active medical therapy (insulin pumps) with restrictive dietary changes early after diagnosis can "restart" the body's natural sugar management system, helping some individuals achieve drug-free remission.
Key Point for Patients: Newly diagnosed type 2 diabetes doesn't always have to be a lifelong progression. Under strict medical care, combining short-term insulin therapy with a low-carb lifestyle could help put your diabetes into remission.
Smoking and diabetic nephropathy: An updated systematic review and meta-analysis
Research Objective: To settle the scientific debate on whether smoking (including former smoking) directly increases the risk of developing diabetic kidney disease (nephropathy).
Methods: A comprehensive review combining data from 15 high-quality studies tracking a total of 221,821 subjects over time, analyzing both type 1 and type 2 diabetes groups.
Main Findings: Active smoking was strongly and significantly associated with an increased risk of diabetic kidney disease. Furthermore, former smokers also remained at a significantly higher risk compared to people who have never smoked. This elevated risk was true for both type 1 and type 2 diabetes patients.
Clinical Significance: This massive analysis confirms that tobacco use is a major, modifiable risk factor for kidney failure in diabetic individuals, establishing an urgent need for smoking cessation support.
Key Point for Patients: Smoking damages your kidneys' delicate blood vessels. Quitting smoking as early as possible is one of the most powerful steps you can take to protect your kidneys from diabetes-related damage.
